Tumor necrosis factor increases serum leptin levels in humans

Area of Science:

• Endocrinology
• Oncology
• Immunology

Background:

• Leptin is a hormone primarily known for regulating body weight.
• The role of leptin in inflammatory disease and cancer-related wasting in humans remains unclear.
• Tumor necrosis factor (TNF) is a key inflammatory cytokine implicated in various disease states.

Purpose of the Study:

• To investigate the impact of tumor necrosis factor (TNF) infusion on serum leptin levels in patients with solid tumors.
• To determine if TNF influences leptin regulation in the context of cancer and inflammation.

Main Methods:

• Serum leptin levels were measured in six patients with solid tumors.
• Repeated infusions of tumor necrosis factor (TNF) were administered.
• Leptin concentrations were assessed at baseline, 12 hours, and 24 hours post-infusion.

Main Results:

• A single TNF infusion elevated serum leptin levels from 3.1 ng/mL to 5.2 ng/mL within 12 hours (P < 0.001).
• Serum leptin levels returned to baseline within 24 hours after TNF infusion.
• Consistent results were observed with repeated TNF infusions on subsequent days.

Conclusions:

• Serum leptin levels are demonstrably influenced and controlled by tumor necrosis factor (TNF).
• TNF plays a significant role in the acute regulation of leptin in cancer patients.
• This finding sheds light on the complex interplay between inflammation and metabolic hormones in disease.